Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $1375.0000 (10.44%) ($1130.0000 - $1895.0000) on Sat. Nov. 8, 2008. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.83% (three month average) | RSI | 52 | Latest Price | $1375.0000(10.44%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 11.3% a day on average for past five trading days. | Weekly Trend | CAPR advances 1.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting CAPR price | CAPR will decline at least -3.915% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.915% (StdDev 7.83%) | Hourly BBV | 0 () | Intraday Trend | -1.8% | | | |
|
5 Day Moving Average | $1058(29.96%) | 10 Day Moving Average | $950.08(44.72%) | 20 Day Moving Average | $1073.53(28.08%) | To recent high | -46.1% | To recent low | 77.4% | Market Cap | $N/A | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |